Goserelin Helps Preserve Fertility Among Women Undergoing Chemo for HR-Negative Breast Cancer
CHICAGO, IL—Administering the luteinizing hormone-releasing hormone (LHRH) analog goserelin with chemotherapy to women with early-stage, hormone receptor-negative breast cancer reduced premature ovarian failure by 70%, resulting in more pregnancies, compared with chemotherapy alone.